Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS Article Swipe
Tomoki Hirunagi
,
Kentaro Sahashi
,
Kiyoshi Tachikawa
,
Angel Leu
,
Michelle Nguyen
,
Rajesh Mukthavaram
,
Priya Karmali
,
Padmanabh Chivukula
,
Genki Tohnai
,
Madoka Iida
,
Kazunari Onodera
,
Manabu Ohyama
,
Yohei Okada
,
Hideyuki Okano
,
Masahisa Katsuno
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1016/j.omtn.2021.02.007
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1016/j.omtn.2021.02.007
Related Topics
Concepts
Spinal and bulbar muscular atrophy
Trinucleotide repeat expansion
Gene silencing
Small interfering RNA
Spinocerebellar ataxia
Biology
Mutant
RNA interference
Cancer research
Molecular biology
Genetics
Gene
Androgen receptor
Transfection
RNA
Prostate cancer
Cancer
Allele
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.omtn.2021.02.007
- http://www.cell.com/article/S2162253121000421/pdf
- OA Status
- gold
- Cited By
- 27
- References
- 46
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3129881290
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3129881290Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.omtn.2021.02.007Digital Object Identifier
- Title
-
Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNSWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-02-16Full publication date if available
- Authors
-
Tomoki Hirunagi, Kentaro Sahashi, Kiyoshi Tachikawa, Angel Leu, Michelle Nguyen, Rajesh Mukthavaram, Priya Karmali, Padmanabh Chivukula, Genki Tohnai, Madoka Iida, Kazunari Onodera, Manabu Ohyama, Yohei Okada, Hideyuki Okano, Masahisa KatsunoList of authors in order
- Landing page
-
https://doi.org/10.1016/j.omtn.2021.02.007Publisher landing page
- PDF URL
-
https://www.cell.com/article/S2162253121000421/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.cell.com/article/S2162253121000421/pdfDirect OA link when available
- Concepts
-
Spinal and bulbar muscular atrophy, Trinucleotide repeat expansion, Gene silencing, Small interfering RNA, Spinocerebellar ataxia, Biology, Mutant, RNA interference, Cancer research, Molecular biology, Genetics, Gene, Androgen receptor, Transfection, RNA, Prostate cancer, Cancer, AlleleTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
27Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 6, 2024: 6, 2023: 7, 2022: 6, 2021: 2Per-year citation counts (last 5 years)
- References (count)
-
46Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3129881290 |
|---|---|
| doi | https://doi.org/10.1016/j.omtn.2021.02.007 |
| ids.doi | https://doi.org/10.1016/j.omtn.2021.02.007 |
| ids.mag | 3129881290 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/33738134 |
| ids.openalex | https://openalex.org/W3129881290 |
| fwci | 2.54769537 |
| type | article |
| title | Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS |
| biblio.issue | |
| biblio.volume | 24 |
| biblio.last_page | 10 |
| biblio.first_page | 1 |
| grants[0].funder | https://openalex.org/F4320311405 |
| grants[0].award_id | |
| grants[0].funder_display_name | Japan Agency for Medical Research and Development |
| grants[1].funder | https://openalex.org/F4320334764 |
| grants[1].award_id | |
| grants[1].funder_display_name | Japan Society for the Promotion of Science |
| topics[0].id | https://openalex.org/T10949 |
| topics[0].field.id | https://openalex.org/fields/28 |
| topics[0].field.display_name | Neuroscience |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2804 |
| topics[0].subfield.display_name | Cellular and Molecular Neuroscience |
| topics[0].display_name | Genetic Neurodegenerative Diseases |
| topics[1].id | https://openalex.org/T12400 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9976000189781189 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2716 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Neurogenetic and Muscular Disorders Research |
| topics[2].id | https://openalex.org/T10441 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9952999949455261 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Muscle Physiology and Disorders |
| funders[0].id | https://openalex.org/F4320311405 |
| funders[0].ror | https://ror.org/004rtk039 |
| funders[0].display_name | Japan Agency for Medical Research and Development |
| funders[1].id | https://openalex.org/F4320334764 |
| funders[1].ror | https://ror.org/00hhkn466 |
| funders[1].display_name | Japan Society for the Promotion of Science |
| is_xpac | False |
| apc_list.value | 3900 |
| apc_list.currency | USD |
| apc_list.value_usd | 3900 |
| apc_paid.value | 3900 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3900 |
| concepts[0].id | https://openalex.org/C2780434838 |
| concepts[0].level | 5 |
| concepts[0].score | 0.9301548004150391 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1995327 |
| concepts[0].display_name | Spinal and bulbar muscular atrophy |
| concepts[1].id | https://openalex.org/C166252455 |
| concepts[1].level | 4 |
| concepts[1].score | 0.7753671407699585 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q6736610 |
| concepts[1].display_name | Trinucleotide repeat expansion |
| concepts[2].id | https://openalex.org/C119056186 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6482991576194763 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1431332 |
| concepts[2].display_name | Gene silencing |
| concepts[3].id | https://openalex.org/C22615655 |
| concepts[3].level | 4 |
| concepts[3].score | 0.6266107559204102 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q203221 |
| concepts[3].display_name | Small interfering RNA |
| concepts[4].id | https://openalex.org/C2779500118 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6120588183403015 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q899726 |
| concepts[4].display_name | Spinocerebellar ataxia |
| concepts[5].id | https://openalex.org/C86803240 |
| concepts[5].level | 0 |
| concepts[5].score | 0.5986332893371582 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[5].display_name | Biology |
| concepts[6].id | https://openalex.org/C143065580 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5170884132385254 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3285695 |
| concepts[6].display_name | Mutant |
| concepts[7].id | https://openalex.org/C166703698 |
| concepts[7].level | 4 |
| concepts[7].score | 0.47800934314727783 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q201993 |
| concepts[7].display_name | RNA interference |
| concepts[8].id | https://openalex.org/C502942594 |
| concepts[8].level | 1 |
| concepts[8].score | 0.34171634912490845 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[8].display_name | Cancer research |
| concepts[9].id | https://openalex.org/C153911025 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3381746709346771 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[9].display_name | Molecular biology |
| concepts[10].id | https://openalex.org/C54355233 |
| concepts[10].level | 1 |
| concepts[10].score | 0.32484376430511475 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[10].display_name | Genetics |
| concepts[11].id | https://openalex.org/C104317684 |
| concepts[11].level | 2 |
| concepts[11].score | 0.31904327869415283 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[11].display_name | Gene |
| concepts[12].id | https://openalex.org/C61367390 |
| concepts[12].level | 4 |
| concepts[12].score | 0.23230215907096863 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q416601 |
| concepts[12].display_name | Androgen receptor |
| concepts[13].id | https://openalex.org/C54009773 |
| concepts[13].level | 3 |
| concepts[13].score | 0.2264842689037323 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q1429031 |
| concepts[13].display_name | Transfection |
| concepts[14].id | https://openalex.org/C67705224 |
| concepts[14].level | 3 |
| concepts[14].score | 0.1412741243839264 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q11053 |
| concepts[14].display_name | RNA |
| concepts[15].id | https://openalex.org/C2780192828 |
| concepts[15].level | 3 |
| concepts[15].score | 0.08657395839691162 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q181257 |
| concepts[15].display_name | Prostate cancer |
| concepts[16].id | https://openalex.org/C121608353 |
| concepts[16].level | 2 |
| concepts[16].score | 0.08303001523017883 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[16].display_name | Cancer |
| concepts[17].id | https://openalex.org/C180754005 |
| concepts[17].level | 3 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q80726 |
| concepts[17].display_name | Allele |
| keywords[0].id | https://openalex.org/keywords/spinal-and-bulbar-muscular-atrophy |
| keywords[0].score | 0.9301548004150391 |
| keywords[0].display_name | Spinal and bulbar muscular atrophy |
| keywords[1].id | https://openalex.org/keywords/trinucleotide-repeat-expansion |
| keywords[1].score | 0.7753671407699585 |
| keywords[1].display_name | Trinucleotide repeat expansion |
| keywords[2].id | https://openalex.org/keywords/gene-silencing |
| keywords[2].score | 0.6482991576194763 |
| keywords[2].display_name | Gene silencing |
| keywords[3].id | https://openalex.org/keywords/small-interfering-rna |
| keywords[3].score | 0.6266107559204102 |
| keywords[3].display_name | Small interfering RNA |
| keywords[4].id | https://openalex.org/keywords/spinocerebellar-ataxia |
| keywords[4].score | 0.6120588183403015 |
| keywords[4].display_name | Spinocerebellar ataxia |
| keywords[5].id | https://openalex.org/keywords/biology |
| keywords[5].score | 0.5986332893371582 |
| keywords[5].display_name | Biology |
| keywords[6].id | https://openalex.org/keywords/mutant |
| keywords[6].score | 0.5170884132385254 |
| keywords[6].display_name | Mutant |
| keywords[7].id | https://openalex.org/keywords/rna-interference |
| keywords[7].score | 0.47800934314727783 |
| keywords[7].display_name | RNA interference |
| keywords[8].id | https://openalex.org/keywords/cancer-research |
| keywords[8].score | 0.34171634912490845 |
| keywords[8].display_name | Cancer research |
| keywords[9].id | https://openalex.org/keywords/molecular-biology |
| keywords[9].score | 0.3381746709346771 |
| keywords[9].display_name | Molecular biology |
| keywords[10].id | https://openalex.org/keywords/genetics |
| keywords[10].score | 0.32484376430511475 |
| keywords[10].display_name | Genetics |
| keywords[11].id | https://openalex.org/keywords/gene |
| keywords[11].score | 0.31904327869415283 |
| keywords[11].display_name | Gene |
| keywords[12].id | https://openalex.org/keywords/androgen-receptor |
| keywords[12].score | 0.23230215907096863 |
| keywords[12].display_name | Androgen receptor |
| keywords[13].id | https://openalex.org/keywords/transfection |
| keywords[13].score | 0.2264842689037323 |
| keywords[13].display_name | Transfection |
| keywords[14].id | https://openalex.org/keywords/rna |
| keywords[14].score | 0.1412741243839264 |
| keywords[14].display_name | RNA |
| keywords[15].id | https://openalex.org/keywords/prostate-cancer |
| keywords[15].score | 0.08657395839691162 |
| keywords[15].display_name | Prostate cancer |
| keywords[16].id | https://openalex.org/keywords/cancer |
| keywords[16].score | 0.08303001523017883 |
| keywords[16].display_name | Cancer |
| language | en |
| locations[0].id | doi:10.1016/j.omtn.2021.02.007 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2764969478 |
| locations[0].source.issn | 2162-2531 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2162-2531 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Molecular Therapy — Nucleic Acids |
| locations[0].source.host_organization | https://openalex.org/P4310315673 |
| locations[0].source.host_organization_name | Cell Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315673 |
| locations[0].license | cc-by |
| locations[0].pdf_url | http://www.cell.com/article/S2162253121000421/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Molecular Therapy - Nucleic Acids |
| locations[0].landing_page_url | https://doi.org/10.1016/j.omtn.2021.02.007 |
| locations[1].id | pmid:33738134 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Molecular therapy. Nucleic acids |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/33738134 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:7937577 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Mol Ther Nucleic Acids |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7937577 |
| locations[3].id | pmh:oai:doaj.org/article:79bd9cceeed841d9b269bcf61a390b07 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | cc-by-sa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Molecular Therapy: Nucleic Acids, Vol 24, Iss , Pp 1-10 (2021) |
| locations[3].landing_page_url | https://doaj.org/article/79bd9cceeed841d9b269bcf61a390b07 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5000188783 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-1948-0126 |
| authorships[0].author.display_name | Tomoki Hirunagi |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| authorships[0].institutions[0].id | https://openalex.org/I60134161 |
| authorships[0].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Nagoya University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Tomoki Hirunagi |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| authorships[1].author.id | https://openalex.org/A5067326228 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3256-9659 |
| authorships[1].author.display_name | Kentaro Sahashi |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| authorships[1].institutions[0].id | https://openalex.org/I60134161 |
| authorships[1].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | Nagoya University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Kentaro Sahashi |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| authorships[2].author.id | https://openalex.org/A5055577313 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Kiyoshi Tachikawa |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210110004 |
| authorships[2].affiliations[0].raw_affiliation_string | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[2].institutions[0].id | https://openalex.org/I4210110004 |
| authorships[2].institutions[0].ror | https://ror.org/01t92qx25 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210110004 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Arcturus Therapeutics (United States) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Kiyoshi Tachikawa |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[3].author.id | https://openalex.org/A5088423539 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Angel Leu |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210110004 |
| authorships[3].affiliations[0].raw_affiliation_string | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[3].institutions[0].id | https://openalex.org/I4210110004 |
| authorships[3].institutions[0].ror | https://ror.org/01t92qx25 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210110004 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Arcturus Therapeutics (United States) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Angel I. Leu |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[4].author.id | https://openalex.org/A5074254926 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Michelle Nguyen |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210110004 |
| authorships[4].affiliations[0].raw_affiliation_string | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[4].institutions[0].id | https://openalex.org/I4210110004 |
| authorships[4].institutions[0].ror | https://ror.org/01t92qx25 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210110004 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Arcturus Therapeutics (United States) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Michelle Nguyen |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[5].author.id | https://openalex.org/A5061675391 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Rajesh Mukthavaram |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210110004 |
| authorships[5].affiliations[0].raw_affiliation_string | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[5].institutions[0].id | https://openalex.org/I4210110004 |
| authorships[5].institutions[0].ror | https://ror.org/01t92qx25 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210110004 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Arcturus Therapeutics (United States) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Rajesh Mukthavaram |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[6].author.id | https://openalex.org/A5005125907 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Priya Karmali |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210110004 |
| authorships[6].affiliations[0].raw_affiliation_string | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[6].institutions[0].id | https://openalex.org/I4210110004 |
| authorships[6].institutions[0].ror | https://ror.org/01t92qx25 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210110004 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Arcturus Therapeutics (United States) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Priya P. Karmali |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[7].author.id | https://openalex.org/A5034398624 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Padmanabh Chivukula |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210110004 |
| authorships[7].affiliations[0].raw_affiliation_string | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[7].institutions[0].id | https://openalex.org/I4210110004 |
| authorships[7].institutions[0].ror | https://ror.org/01t92qx25 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210110004 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Arcturus Therapeutics (United States) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Padmanabh Chivukula |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA |
| authorships[8].author.id | https://openalex.org/A5000652345 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Genki Tohnai |
| authorships[8].countries | JP |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| authorships[8].institutions[0].id | https://openalex.org/I60134161 |
| authorships[8].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[8].institutions[0].country_code | JP |
| authorships[8].institutions[0].display_name | Nagoya University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Genki Tohnai |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| authorships[9].author.id | https://openalex.org/A5000233353 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-3394-9760 |
| authorships[9].author.display_name | Madoka Iida |
| authorships[9].countries | JP |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| authorships[9].institutions[0].id | https://openalex.org/I60134161 |
| authorships[9].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[9].institutions[0].country_code | JP |
| authorships[9].institutions[0].display_name | Nagoya University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Madoka Iida |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| authorships[10].author.id | https://openalex.org/A5022258284 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-3274-0260 |
| authorships[10].author.display_name | Kazunari Onodera |
| authorships[10].countries | JP |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I16528096 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Neurology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute-shi, Aichi 480-1195, Japan |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I60134161 |
| authorships[10].affiliations[1].raw_affiliation_string | Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| authorships[10].institutions[0].id | https://openalex.org/I16528096 |
| authorships[10].institutions[0].ror | https://ror.org/02h6cs343 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I16528096 |
| authorships[10].institutions[0].country_code | JP |
| authorships[10].institutions[0].display_name | Aichi Medical University |
| authorships[10].institutions[1].id | https://openalex.org/I60134161 |
| authorships[10].institutions[1].ror | https://ror.org/04chrp450 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I60134161 |
| authorships[10].institutions[1].country_code | JP |
| authorships[10].institutions[1].display_name | Nagoya University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Kazunari Onodera |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Neurology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute-shi, Aichi 480-1195, Japan, Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| authorships[11].author.id | https://openalex.org/A5002193039 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-2662-5717 |
| authorships[11].author.display_name | Manabu Ohyama |
| authorships[11].countries | JP |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210107168 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan |
| authorships[11].institutions[0].id | https://openalex.org/I4210107168 |
| authorships[11].institutions[0].ror | https://ror.org/01k8ej563 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210107168 |
| authorships[11].institutions[0].country_code | JP |
| authorships[11].institutions[0].display_name | Keio University Hospital |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Manabu Ohyama |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan |
| authorships[12].author.id | https://openalex.org/A5031774551 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5253-8556 |
| authorships[12].author.display_name | Yohei Okada |
| authorships[12].countries | JP |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I16528096 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Neurology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute-shi, Aichi 480-1195, Japan |
| authorships[12].institutions[0].id | https://openalex.org/I16528096 |
| authorships[12].institutions[0].ror | https://ror.org/02h6cs343 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I16528096 |
| authorships[12].institutions[0].country_code | JP |
| authorships[12].institutions[0].display_name | Aichi Medical University |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Yohei Okada |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Neurology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute-shi, Aichi 480-1195, Japan |
| authorships[13].author.id | https://openalex.org/A5035479034 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-7482-5935 |
| authorships[13].author.display_name | Hideyuki Okano |
| authorships[13].countries | JP |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210107168 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan |
| authorships[13].institutions[0].id | https://openalex.org/I4210107168 |
| authorships[13].institutions[0].ror | https://ror.org/01k8ej563 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210107168 |
| authorships[13].institutions[0].country_code | JP |
| authorships[13].institutions[0].display_name | Keio University Hospital |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Hideyuki Okano |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan |
| authorships[14].author.id | https://openalex.org/A5036681718 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-9453-9311 |
| authorships[14].author.display_name | Masahisa Katsuno |
| authorships[14].countries | JP |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I60134161 |
| authorships[14].affiliations[0].raw_affiliation_string | Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| authorships[14].institutions[0].id | https://openalex.org/I60134161 |
| authorships[14].institutions[0].ror | https://ror.org/04chrp450 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I60134161 |
| authorships[14].institutions[0].country_code | JP |
| authorships[14].institutions[0].display_name | Nagoya University |
| authorships[14].author_position | last |
| authorships[14].raw_author_name | Masahisa Katsuno |
| authorships[14].is_corresponding | True |
| authorships[14].raw_affiliation_strings | Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Syowa-ku, Nagoya, Aichi 466-8550, Japan |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.cell.com/article/S2162253121000421/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10949 |
| primary_topic.field.id | https://openalex.org/fields/28 |
| primary_topic.field.display_name | Neuroscience |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2804 |
| primary_topic.subfield.display_name | Cellular and Molecular Neuroscience |
| primary_topic.display_name | Genetic Neurodegenerative Diseases |
| related_works | https://openalex.org/W4243997267, https://openalex.org/W2061545419, https://openalex.org/W1998361697, https://openalex.org/W2031559689, https://openalex.org/W2052836084, https://openalex.org/W2280080604, https://openalex.org/W19962924, https://openalex.org/W1147203815, https://openalex.org/W2066422271, https://openalex.org/W1513481287 |
| cited_by_count | 27 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 6 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 6 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 7 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 6 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 2 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1016/j.omtn.2021.02.007 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764969478 |
| best_oa_location.source.issn | 2162-2531 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2162-2531 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Molecular Therapy — Nucleic Acids |
| best_oa_location.source.host_organization | https://openalex.org/P4310315673 |
| best_oa_location.source.host_organization_name | Cell Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315673 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | http://www.cell.com/article/S2162253121000421/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Molecular Therapy - Nucleic Acids |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.omtn.2021.02.007 |
| primary_location.id | doi:10.1016/j.omtn.2021.02.007 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2764969478 |
| primary_location.source.issn | 2162-2531 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2162-2531 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Molecular Therapy — Nucleic Acids |
| primary_location.source.host_organization | https://openalex.org/P4310315673 |
| primary_location.source.host_organization_name | Cell Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315673 |
| primary_location.license | cc-by |
| primary_location.pdf_url | http://www.cell.com/article/S2162253121000421/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Molecular Therapy - Nucleic Acids |
| primary_location.landing_page_url | https://doi.org/10.1016/j.omtn.2021.02.007 |
| publication_date | 2021-02-16 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W4242614327, https://openalex.org/W2113333419, https://openalex.org/W2887748872, https://openalex.org/W2755227731, https://openalex.org/W2950526133, https://openalex.org/W2988303188, https://openalex.org/W2077164928, https://openalex.org/W2007578481, https://openalex.org/W2018829484, https://openalex.org/W2162932379, https://openalex.org/W1988261092, https://openalex.org/W2135372036, https://openalex.org/W2065946475, https://openalex.org/W2022382975, https://openalex.org/W2117502301, https://openalex.org/W2587247473, https://openalex.org/W2963464328, https://openalex.org/W1894534815, https://openalex.org/W2291779372, https://openalex.org/W2529432601, https://openalex.org/W2009045250, https://openalex.org/W2013452556, https://openalex.org/W2062682951, https://openalex.org/W2045341029, https://openalex.org/W2097243324, https://openalex.org/W3028143627, https://openalex.org/W2050679356, https://openalex.org/W2167400349, https://openalex.org/W2072821281, https://openalex.org/W2153931198, https://openalex.org/W2885305111, https://openalex.org/W2143743183, https://openalex.org/W2600400434, https://openalex.org/W2166483989, https://openalex.org/W2173365046, https://openalex.org/W2751943521, https://openalex.org/W2103802203, https://openalex.org/W2016363609, https://openalex.org/W2014643086, https://openalex.org/W1954017951, https://openalex.org/W2587871737, https://openalex.org/W3011656467, https://openalex.org/W2974722966, https://openalex.org/W2163536301, https://openalex.org/W1985902870, https://openalex.org/W2912804808 |
| referenced_works_count | 46 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 93 |
| corresponding_author_ids | https://openalex.org/A5067326228, https://openalex.org/A5036681718 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 15 |
| corresponding_institution_ids | https://openalex.org/I60134161 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7300000190734863 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.88082748 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |